Arcadia Vice President of Enterprise Partnerships, Anna Basevich, recently spoke with IMSNY CIO, Elise Kohl-Grant, about the lack of technology investment in behavioral health, how standardized data could open doors for new patient benefits, and why technology can lead to significant positive outcomes for the whole person care.
Arcadia Chief Product Officer, Nick Stepro and Castell Medical Director and Interim COO, Dr. Will Daines, discuss realigning payers and medical providers around mutual benefits value-based care, the technology needed to deploy that change, and the outcomes that it delivers to patients, providers, and payers.
Arcadia's new study, published on medRxiv, shows that current vaccines reduce the risk of long-COVID, even when administered up to 12 weeks after a COVID diagnosis.
Arcadia just released a new study showing that getting vaccinated for COVID-19 reduces the indidence and severity of long-COVID. Here, we explain the research and findings.
Clinical trials and studies of real-world evidence have demonstrated repeatedly that the three COVID-19 vaccines* authorized for emergency use or approved for use by the Food and Drug Administration are safe and effective at preventing COVID-19 infection, hospitalization, and death (1). A recent observational study of self-reported symptoms goes further, concluding that vaccination may also reduce the likelihood and intensity of long-COVID (2), a proposal that has been raised anecdotally, as well (3). As part of a federated research study with the COVID-19 Patient Recovery Alliance, Arcadia.io performed a retrospective analysis of the medical history of 240,648 COVID-19-infected persons to identity factors influencing the development and progression of long-COVID. This analysis revealed that patients who received at least one dose of any of the three COVID vaccines prior to their diagnosis with COVID-19 were 7-10 times less likely to report two or more long-COVID symptoms† compared to unvaccinated patients. Furthermore, unvaccinated patients who received their first COVID-19 vaccination within four weeks of SARS-CoV-2 infection were 4-6 times less likely to report multiple long-COVID symptoms, and those who received their first dose 4-8 weeks after diagnosis were still 3 times less likely to report multiple long-COVID symptoms compared to those who remained unvaccinated. This relationship supports the hypothesis that COVID-19 vaccination is protective against long-COVID and that that effect persists even if vaccination occurs up to 12 weeks after COVID-19 diagnosis.
Health equity, reaching vulnerable populations, and keeping up with changes in the way healthcare is delivered. Here's Rush Health President and Executive Director Anthony Del Rio's perspective on how providers and the health systems they work within are rising to meet these enormous challenges.
Arcadia Vice President of Enterprise Partnerships, Anna Basevich, and KLAS Research Director, Bradley Hunter, discuss shifts in the marketplace and how more providers can access the benefits of at-risk models through key strategic initiatives.
There are many different ways to run a TCM program, but Arcadia customers performing well in this area typically follow a core approach. ACOs can encourage their PCPs to adopt these practices and improve MSSP results with this 7-step process.
There’s a well-established opportunity for ACOs to deliver better quality care to patients and improve MSSP results through end-of-life care. Here's how to get your PCPs onboard.
Our cloud-based, HIPAA-compliant Arcadia Analytics Population Health Platform is purpose-built with best-in-class big data technology to support high availability data ingestion, computation and storage.
We extract rich, useful clinical EHR data and combine it with adjudicated claims systems, SDoH data, ADT feeds and more to build a high-quality, continually updated enterprise data asset that powers your success in value-based care.
Illuminate drivers of cost and utilization, measure performance, find and close risk and quality gaps, identify impactable patients for care management and outreach. The result: reduced TME, more accurate risk adjustment and improved quality.
Achieve better and more sustainable financial outcomes by combining the most comprehensive patient view with actionable AI-powered insights into care team-centered workflows for outreach, documentation, tasking and care coordination.